These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24211780)

  • 1. Inhibitory effects of pitavastatin on fibrogenic mediator production by human lung fibroblasts.
    Oka H; Ishii H; Iwata A; Kushima H; Toba S; Hashinaga K; Umeki K; Tokimatsu I; Hiramatsu K; Kadota J
    Life Sci; 2013 Dec; 93(25-26):968-74. PubMed ID: 24211780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
    Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
    FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
    Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
    Burke JP; Watson RW; Murphy M; Docherty NG; Coffey JC; O'Connell PR
    Br J Surg; 2009 May; 96(5):541-51. PubMed ID: 19358180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts.
    Park IH; Park SJ; Cho JS; Moon YM; Moon JH; Kim TH; Lee SH; Lee HM
    Am J Rhinol Allergy; 2012; 26(1):7-11. PubMed ID: 22391067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
    Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
    Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.
    Tannheimer SL; Wright CD; Salmon M
    Respir Res; 2012 Mar; 13(1):28. PubMed ID: 22452977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.
    Kadoya K; Togo S; Tulafu M; Namba Y; Iwai M; Watanabe J; Okabe T; Jin J; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Takeda T; Kondo N; Takahashi K
    Cell Physiol Biochem; 2019; 52(4):822-837. PubMed ID: 30946557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppression effects of thalidomide on human lung fibroblasts: cell proliferation, vascular endothelial growth factor release, and collagen production.
    Tseng CM; Hsiao YH; Su VY; Su KC; Wu YC; Chang KT; Perng DW
    Lung; 2013 Aug; 191(4):361-8. PubMed ID: 23722461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.
    Watts KL; Cottrell E; Hoban PR; Spiteri MA
    Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
    Kim S; Lim JH; Woo CH
    Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts.
    Hsieh YP; Chen HM; Lin HY; Yang H; Chang JZ
    J Formos Med Assoc; 2017 Feb; 116(2):107-113. PubMed ID: 26922429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of transforming growth factor-β
    Li HH; Cai Q; Wang YP; Liu HR; Huang M
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Jul; 34(7):484-488. PubMed ID: 27682480
    [No Abstract]   [Full Text] [Related]  

  • 17. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
    Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
    Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways.
    Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L
    Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
    Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
    Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.